Mitochondrial disease patient motivations and barriers to participate in clinical trials von Zolkipli-Cunningham, Zarazuela, Xiao, Rui, Stoddart, Amy, McCormick, Elizabeth M, Holberts, Amy, Burrill, Natalie, McCormack, Shana, Williams, Lauren, Wang, Xiaoyan, Thompson, John L P, Falk, Marni J

Volltext

Is Interview Length Associated With Blood Test Participation? Evidence From Three Population-Based HIV Impact Assessment Surveys Conducted From 2016 to 2017 von Bray, Rachel, Palma, Anton M., Philip, Neena M., Brown, Kristin, Levin, Bruce, Thompson, John L. P. (Seamus), Ginindza, Choice, Mulenga, Lloyd B.

Volltext

Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke Results of a Prematurely Terminated Randomized Clinical Trial von HALEY, E. Clarke, THOMPSON, John L. P, LEVINE, Steven R, JOHNSTON, Karen C, BUCHSBAUM, Richard, LEVY, Gilberto, LEVIN, Bruce, GROTTA, James C, LYDEN, Patrick D, HEMMEN, Thomas G, BROWN, Devin L, FANALE, Christopher, LIBMAN, Richard, KWIATKOWSKI, Thomas G, LLINAS, Rafael H

Volltext

The evolution of the mitochondrial disease diagnostic odyssey von Thompson, John L P, Karaa, Amel, Pham, Hung, Yeske, Philip, Krischer, Jeffrey, Xiao, Yi, Long, Yuelin, Kramer, Amanda, Dimmock, David, Holbert, Amy, Gorski, Cliff, Engelstad, Kristin M, Buchsbaum, Richard, Rosales, Xiomara Q, Hirano, Michio

Volltext

Correction to: The evolution of the mitochondrial disease diagnostic odyssey von Thompson, John L P, Karaa, Amel, Pham, Hung, Yeske, Philip, Krischer, Jeffrey, Xiao, Yi, Long, Yuelin, Kramer, Amanda, Dimmock, David, Holbert, Amy, Gorski, Cliff, Engelstad, Kristin M, Buchsbaum, Richard, Rosales, Xiomara Q, Hirano, Michio

Volltext

Amino Terminal Pro―B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy von LONGSTRETH, W. T, KRONMAL, Richard A, SELIGER, Stephen L, MOHR, J. P, DEFILIPPI, Christopher R, THOMPSON, John L. P, CHRISTENSON, Robert H, LEVINE, Steven R, GROSS, Rebecca, BREY, Robin L, BUCHSBAUM, Richard, ELKIND, Mitchell S. V, TIRSCHWELL, David L

Volltext

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III von Kaufmann, Petra, Thompson, John L.P., Levy, Gilberto, Buchsbaum, Richard, Shefner, Jeremy, Krivickas, Lisa S., Katz, Jonathan, Rollins, Yvonne, Barohn, Richard J., Jackson, Carlayne E., Tiryaki, Ezgi, Lomen-Hoerth, Catherine, Armon, Carmel, Tandan, Rup, Rudnicki, Stacy A., Rezania, Kourosh, Sufit, Robert, Pestronk, Alan, Novella, Steven P., Heiman-Patterson, Terry, Kasarskis, Edward J., Pioro, Erik P., Montes, Jacqueline, Arbing, Rachel, Vecchio, Darleen, Barsdorf, Alexandra, Mitsumoto, Hiroshi, Levin, Bruce

Volltext

Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC) von Emmanuele, Valentina, Ganesh, Jaya, Vladutiu, Georgirene, Haas, Richard, Kerr, Douglas, Saneto, Russell P., Cohen, Bruce H., Van Hove, Johan L.K., Scaglia, Fernando, Hoppel, Charles, Rosales, Xiomara Q., Barca, Emanuele, Buchsbaum, Richard, Thompson, John L., DiMauro, Salvatore, Hirano, Michio

Volltext

Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial von Romiti, Giulio Francesco, Nabrdalik, Katarzyna, Corica, Bernadette, Bucci, Tommaso, Proietti, Marco, Qian, Min, Chen, Yineng, Thompson, John L. P., Homma, Shunichi, Lip, Gregory Y. H.

Volltext

Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trial von Stacpoole, Peter W, Shuster, Jonathan, Thompson, John L P Seamus, Prather, Robert A, Lawson, Lee Ann, Zou, Baiming, Buchsbaum, Richard, Nixon, Sara Jo

Volltext

Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy von Engelstad, Kristin, Sklerov, Miriam, Kriger, Joshua, Sanford, Alexandra, Grier, Johnston, Ash, Daniel, Egli, Dieter, DiMauro, Salvatore, Thompson, John L.P., Sauer, Mark V., Hirano, Michio

Volltext

Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial) von Lee, Tetz C., Qian, Min, Lip, Gregory Y.H., Di Tullio, Marco R., Graham, Susan, Mann, Douglas L., Nakanishi, Koki, Teerlink, John R., Freudenberger, Ronald S., Sacco, Ralph L., Mohr, J.P., Labovitz, Arthur J., Ponikowski, Piotr, Lok, Dirk J., Estol, Conrado, Anker, Stefan D., Pullicino, Patrick M., Buchsbaum, Richard, Levin, Bruce, Thompson, John L.P., Homma, Shunichi, Ye, Siqin

Volltext

Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm von Homma, Shunichi, Thompson, John L.P, Pullicino, Patrick M, Levin, Bruce, Freudenberger, Ronald S, Teerlink, John R, Ammon, Susan E, Graham, Susan, Sacco, Ralph L, Mann, Douglas L, Mohr, J.P, Massie, Barry M, Labovitz, Arthur J, Anker, Stefan D, Lok, Dirk J, Ponikowski, Piotr, Estol, Conrado J, Lip, Gregory Y.H, Di Tullio, Marco R, Sanford, Alexandra R, Mejia, Vilma, Gabriel, Andre P, del Valle, Mirna L, Buchsbaum, Richard

Volltext

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial von Graham, Susan, Ye, Siqin, Qian, Min, Sanford, Alexandra R, Di Tullio, Marco R, Sacco, Ralph L, Mann, Douglas L, Levin, Bruce, Pullicino, Patrick M, Freudenberger, Ronald S, Teerlink, John R, Mohr, J P, Labovitz, Arthur J, Lip, Gregory Y H, Estol, Conrado J, Lok, Dirk J, Ponikowski, Piotr, Anker, Stefan D, Thompson, John L P, Homma, Shunichi

Volltext

Designing Clinical Trials for Dystonia von Galpern, Wendy R., Coffey, Christopher S., Albanese, Alberto, Cheung, Ken, Comella, Cynthia L., Ecklund, Dixie J., Fahn, Stanley, Jankovic, Joseph, Kieburtz, Karl, Lang, Anthony E., McDermott, Michael P., Shefner, Jeremy M., Teller, Jan K., Thompson, John L. P., Yeatts, Sharon D., Jinnah, H. A.

Volltext

Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials von Huang, Xuya, MacIsaac, Rachael, Thompson, John LP, Levin, Bruce, Buchsbaum, Richard, Haley, E Clarke, Levi, Christopher, Campbell, Bruce, Bladin, Christopher, Parsons, Mark, Muir, Keith W

Volltext

Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial von Gue, Ying, Correa, Elon, Thompson, John L.P., Homma, Shunichi, Qian, Min, Lip, Gregory Y.H.

Volltext

Towards a model of entrepreneurial behaviour: an evaluation of the history of Fabergé from 1842 to 2017 von Thompson, John L., Day, John

Volltext

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin von Ye, Siqin, MS, MD, Cheng, Bin, PhD, Lip, Gregory Y.H., MD, Buchsbaum, Richard, Sacco, Ralph L., MD, Levin, Bruce, PhD, Di Tullio, Marco R., MD, Qian, Min, PhD, Mann, Douglas L., MD, Pullicino, Patrick M., MD, Freudenberger, Ronald S., MD, Teerlink, John R., MD, Mohr, J.P., MD, Graham, Susan, MD, Labovitz, Arthur J., MD, Estol, Conrado J., MD, PhD, Lok, Dirk J., MD, Ponikowski, Piotr, MD, PhD, Anker, Stefan D., MD, PhD, Thompson, John L.P., PhD, Homma, Shunichi, MD

Volltext

Deoxynucleoside Therapy for Thymidine Kinase 2–Deficient Myopathy von Domínguez‐González, Cristina, Madruga‐Garrido, Marcos, Mavillard, Fabiola, Garone, Caterina, Aguirre‐Rodríguez, Francisco Javier, Donati, M. Alice, Kleinsteuber, Karin, Martí, Itxaso, Martín‐Hernández, Elena, Morealejo‐Aycinena, Juan P., Munell, Francina, Nascimento, Andrés, Kalko, Susana G., Sardina, M. Dolores, Álvarez del Vayo, Concepcion, Serrano, Olga, Long, Yuelin, Tu, Yuqi, Levin, Bruce, Thompson, John L. P., Engelstad, Kristen, Uddin, Jasim, Torres‐Torronteras, Javier, Jimenez‐Mallebrera, Cecilia, Martí, Ramon, Paradas, Carmen, Hirano, Michio

Volltext